
Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. (TPST)
WebsitePrice
Market cap
Next catalystU.S. registrational study initiation in Q4 2026, subject to regulatory clearancetpst-2003 · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
Other pipelines
Partner / License out
TPST-3206
CD70
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2FilingApproved
PreINDP1P2P3FilingApproved